Overview and Scope
Smart inhalers refer to medical devices that integrate connectivity with a mobile app, typically via Bluetooth. It is used to enhance the user experience and provide more personalized treatment decisions for individuals with chronic lung conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Sizing and Forecast
The smart inhalers market size has grown strongly in recent years. It will grow from $1.48 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increased medical adherence, increasing focus on patient-centric healthcare, growing demand for connected healthcare devices.
The smart inhalers market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to rising prevalence of chronic respiratory diseases (CRDs), growing demand for home healthcare, increasing adoption of digital healthcare solutions. Major trends in the forecast period include technological advancements in smart inhalers, big data analytics, use of chip-on-sensors, advancements in sensor technology.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report
The smart inhalers market covered in this report is segmented –
1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Hospitals, Homecare Settings, Other End-Users
North America was the largest region in the smart inhalers market in 2023. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14196&type=smp
Major Driver Impacting Market Growth
The rising prevalence of chronic respiratory diseases (CRDs) is expected to boost the growth of the smart inhaler market going forward. Chronic respiratory diseases (CRDs) encompass a range of long-term conditions that affect the airways and other structures of the lungs. Smart inhalers, by tracking usage and offering reminders for missed doses, manage chronic respiratory diseases such as asthma and COPD, ensuring consistent medication use for symptom control and prevention of exacerbations. For instance, in June 2023, according to reports shared by the Australian Institute of Health and Welfare, an Australia-based national agency, there was a rise in respiratory disease-related deaths from 43,031 in 2020 to 46,551 in 2021 in Australia. Furthermore, in September 2022, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, 11,255 new cases of RSV (respiratory syncytial virus) were recorded in 2021. Therefore, the rising prevalence of chronic respiratory diseases (CRDs) is driving the growth of the smart inhaler market.
Key Industry Players
Major companies operating in the smart inhalers market are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.
The smart inhalers market report table of contents includes:
1. Executive Summary
2. Smart Inhalers Market Characteristics
3. Smart Inhalers Market Trends And Strategies
4. Smart Inhalers Market – Macro Economic Scenario
5. Global Smart Inhalers Market Size and Growth
……….
32. Global Smart Inhalers Market Competitive Benchmarking
33. Global Smart Inhalers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Smart Inhalers Market
35. Smart Inhalers Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
